Abstract
Background
The European Working Group on Sarcopenia in Older People (EWGSOP) recently updated the definition and diagnostic criteria to assess sarcopenia, which can result in important changes in sarcopenia prevalence in older adults.
Aim
To compare the prevalence of sarcopenia through the diagnostic criteria and definition proposed by the first (EWGSOP1) and recent (EWGSOP2) European consensus in older adults. We also aimed to evaluate which sarcopenia consensus is better associated with unfavorable health outcomes.
Methods
The review followed PRISMA guidelines. Embase, Medline (PubMed), Scopus and Web of Science were searched from 2018 to February 2021. The systematic review protocol was registered at PROSPERO (CRD42020213303). The search, selection, and evaluation processes were done in a duplicate and independent manner.
Results
Of the 298 potentially eligible articles, 9 were included in this review. The prevalence of sarcopenia was 17.7% by EWGSOP1 and 11% by EWGSOP2. Evaluating all the studies, the sarcopenia prevalence ranged from 6.2 to 35.3% for the EWGSOP1, and from 3.2 to 26.3% for the EWGSOP2. Five studies have evaluated the association between the prevalence of sarcopenia (EWGSOP1 versus EWGSOP2) and unfavorable health outcomes, in which three studies showed that EWGSOP1 was better associated with increased risk of hospitalization and/or mortality.
Conclusion
In comparison with EWGSOP1, the prevalence of sarcopenia in older adults decreased when diagnosed according to EWGSOP2. Based on limited evidence, EWGSOP2 seems to be worse for predicting unfavorable outcomes compared with EWGSOP1.
Similar content being viewed by others
References
Rosenberg IH (1997) Symposium: sarcopenia: diagnosis and mechanisms sarcopenia: origins and clinical relevance 1. J Nutr 127:990–991
Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis. Age Ageing 39:412–423. https://doi.org/10.1093/ageing/afq034
Cruz-Jentoft AJ, Bahat GG, Bauer JJ et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31. https://doi.org/10.1093/ageing/afy169
Kim H, Hirano H, Edahiro A et al (2016) Sarcopenia: prevalence and associated factors based on different suggested definitions in community-dwelling older adults. Geriatr Gerontol Int 16:110–122. https://doi.org/10.1111/ggi.12723
Pagotto V, Silveira EA (2014) Applicability and agreement of different diagnostic criteria for sarcopenia estimation in the elderly. Arch Gerontol Geriatr 59:288–294. https://doi.org/10.1016/j.archger.2014.05.009
Bachettini NP, Bielemann RM, Barbosa-Silva TG et al (2020) Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the European Working Group on Sarcopenia in Older People. Eur J Clin Nutr 74:573–580. https://doi.org/10.1038/s41430-019-0508-8
Costanzo L, De Vincentis A, Di Iorio A et al (2020) Impact of low muscle mass and low muscle strength according to EWGSOP2 and EWGSOP1 in community-dwelling older people. J Gerontol Ser A 75:1324–1330. https://doi.org/10.1093/gerona/glaa063
Jang I-Y, Lee E, Lee H et al (2020) Characteristics of sarcopenia by European consensuses and a phenotype score. J Cachexia Sarcopenia Muscle 11:497–504. https://doi.org/10.1002/jcsm.12507
Downes MJ, Brennan ML, Williams HC, Dean RS (2016) Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open 6:1–7. https://doi.org/10.1136/bmjopen-2016-011458
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. In: Ottawa Hosp. Res. Inst. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Beaudart C, Zaaria M, Pasleau F et al (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS ONE 12:1–16. https://doi.org/10.1371/journal.pone.0169548
Krzymińska-Siemaszko R, Deskur-Śmielecka E, Kaluźniak-Szymanowska A et al (2020) Comparison of diagnostic performance of SARC-F and its two modified versions (SARC-CalF and SARC-F+EBM) in community-dwelling older adults from Poland. Clin Interv Aging 15:583–594. https://doi.org/10.2147/CIA.S250508
Shafiee G, Heshmat R, Ostovar A et al (2020) Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program. J Diabetes Metab Disord. https://doi.org/10.1007/s40200-020-00553-w
Yang L, Yao X, Shen J et al (2019) Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community-dwelling elderly residents. Exp Gerontol 130:110798. https://doi.org/10.1016/j.exger.2019.110798
Tang T, Xie L, Tan L et al (2020) Inflammatory indexes are not associated with sarcopenia in Chinese community-dwelling older people: a cross-sectional study. BMC Geriatr 20:457. https://doi.org/10.1186/s12877-020-01857-5
Locquet M, Beaudart C, Petermans J et al (2019) EWGSOP2 versus EWGSOP1: impact on the prevalence of sarcopenia and its major health consequences. J Am Med Dir Assoc 20:384–385. https://doi.org/10.1016/j.jamda.2018.11.027
Sobestiansky S, Michaelsson K, Cederholm T (2019) Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85–89 year old community-dwelling men: a report from the ULSAM study. BMC Geriatr. https://doi.org/10.1186/s12877-019-1338-1
Krzyminska-Siemaszko R, Deskur-Smielecka E, Kaluzniak-Szymanowska A et al (2020) Comparison of diagnostic performance of sarc-f and its two modified versions (SARC-CaIF and SARC-F plus EBM) in community-dwelling older adults from Poland. Clin Interv Aging 15:583–594. https://doi.org/10.2147/CIA.S250508
Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763. https://doi.org/10.1093/oxfordjournals.aje.a009520
Janssen I, Heymsfield SB, Ross R (2002) Low Relative skeletal muscle mass (Sarcopenia) in older persons is associated with functional impairment and physical disability. Am Geriatr Soc 50:889–896. https://doi.org/10.1046/j.1532-5415.2002.50216.x
Sergi G, De Rui M, Veronese N et al (2015) Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin Nutr 34:667–673. https://doi.org/10.1016/j.clnu.2014.07.010
Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia. Lancet 393:2636–2646. https://doi.org/10.1016/S0140-6736(19)31138-9
Martone AM, Marzetti E, Salini S et al (2020) Sarcopenia identified according to the EWGSOP2 definition in community-living people: prevalence and clinical features. J Am Med Dir Assoc 21:1470–1474. https://doi.org/10.1016/j.jamda.2020.03.007
Cruz RPF, Barreiro SM, Mendonça AM et al (2020) Calf circumference is similarly associated with fat mass and lean mass in postmenopausal women with high body fat percentage. Nutrire 45:6. https://doi.org/10.1186/s41110-019-0109-2
Phu S, Vogrin S, Zanker J et al (2019) Agreement between initial and revised european working group on sarcopenia in older people definitions. J Am Med Dir Assoc 20:382-383.e1. https://doi.org/10.1016/j.jamda.2018.11.026
Yee XS, Ng YS, Allen JC et al (2021) Performance on sit-to-stand tests in relation to measures of functional fitness and sarcopenia diagnosis in community-dwelling older adults. Eur Rev Aging Phys Act 18:1–11. https://doi.org/10.1186/s11556-020-00255-5
Funding
This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001, National Council for Scientific and Technological Development (CNPq) and Federal University of Lavras (UFLA). EPO would like to thank “Conselho Nacional de Desenvolvimento Científico e Tecnológico” (CNPq, Brazil, 304205/2019-2).
Author information
Authors and Affiliations
Contributions
LVF, AEGP, and ACBS designed the study, developed the study protocol, and performed all analyses, and oversaw the management of all aspects of the study. LVF and AEGP conducted the literature search and participated in screening, full-text review, and data extraction. ICC, AFS, EPO, and LCJP participated full-text review and advised on analysis and contributed to the interpretation of findings. EPO and LCJP contributed equally to this work. All authors contributed to the writing of the final manuscript and approved the final version for submission.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Statement of human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fernandes, L.V., Paiva, A.E.G., Silva, A.C.B. et al. Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review. Aging Clin Exp Res 34, 505–514 (2022). https://doi.org/10.1007/s40520-021-01951-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-021-01951-7